Status:
COMPLETED
The Features Behind the Beneficial Effects of Interval-walking
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
30+ years
Phase:
NA
Brief Summary
A single bout of Interval-Walking (IW) exercise is superior to energy-expenditure and time-duration matched Continuous Walking (CW) exercise upon improving glycemic control. The reason IW is superior ...
Eligibility Criteria
Inclusion
- Type 2 diabetes mellitus
- Body mass index \> 18 but \< 40 m2/kg
- Agreement to pause antidiabetic medication from 2 days before to after each trial
Exclusion
- Pregnancy
- Smoking
- Use of exogenous insulin
- Contraindication to increased levels of physical activity
- Evidence of thyroid, liver, lung, heart or kidney disease
Key Trial Info
Start Date :
October 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2015
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT02257190
Start Date
October 1 2014
End Date
October 1 2015
Last Update
October 29 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center for Physical Activity Research (CFAS)
Copenhagen, Denmark, 2100